首页 > 市场调查报告书 > 材料

市场调查报告书

商品编码

1410102

防腐剂和消毒剂市场：2023-2028 年预测

Antiseptic and Disinfectant Market - Forecasts from 2023 to 2028

出版日期: 2023年12月13日 | 出版商:

Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

防腐剂和消毒剂市场预计在预测期内复合年增长率为 12.38%。

防腐剂广泛用于医疗机构的局部和硬表面应用。与抗生素相比，这些活性化合物大多具有广谱抗菌活性，但对其作用方式知之甚少。由于防腐剂和消毒剂的广泛使用，关于微生物抗药性的出现存在很大争议，特别是抗菌素抗药性是否是由防腐剂或消毒剂介导的。

防腐剂和消毒剂市场的成长动力

感染疾病引起的疾病增加是防腐剂和消毒剂市场的主要成长动力。随着世界各地的人们越来越容易感染疾病引起的疾病，人们必须采取预防措施。行业巨头的广泛研究和开发计划正在推动防腐剂和消毒剂的市场占有率。这些製造商增加投资也是防腐剂和消毒剂市场成长的关键因素。

HAI 增加

防腐剂和消毒剂市场扩张的关键驱动因素之一是由于缺乏卫生和安全措施而导致的医院感染增加。例如，在医疗保健相关感染中，据估计，每年入院的患者中大约有二分之一至少发生一次医院感染。防腐剂和消毒剂在整体污染、预防和减少 HAI 频率方面发挥重要作用。防腐消毒剂产品进一步促进了防腐消毒剂市场的发展，因为它们可以保护患者的身体免受所有细菌和微生物的感染。

多种报销政策代表着巨大的成长机会

保险公司向客户提供许多有吸引力的报销计划，帮助他们选择尖端的治疗技术，从而促进防腐剂和消毒剂市场的成长。儘管可支配收入较低，但仍鼓励采取报销策略，为这些族群提供治疗选择。随着受感染疾病影响的人数增加，核准的报销数量也增加。

表面消毒剂预计将成长

称为表面消毒剂的化学物质用于杀死或惰性惰性表面上的细菌。这些消毒剂透过破坏微生物的细胞壁或抑制其新陈代谢来发挥作用。透过彻底的表面清洗，也可以避免患者入院时不存在或潜伏的感染疾病。表面消毒剂包括用于不同目的的化学物质。根据世界卫生组织 (WHO) 2022 年 3 月更新的资料，在非医疗保健环境中，使用建议剂量为 0.1% 或 1,000 ppm 的次氯酸钠（漂白剂/氯）即可。 70-90% 浓度的酒精也可用于消毒表面。

医疗设备消毒剂预计将大幅成长

手术设备和内视镜通常使用医疗设备消毒剂再处理。苯酚、过氧化氢、过氧乙酸和戊二醛是用于医疗设备再处理和消毒的一些消毒剂。内视镜和医疗设备需要消毒，因为有透过皮肤接触在患者之间传播感染的风险。全球外科手术数量的增加也是推动防腐消毒剂市场成长的主要因素之一。

对酒精类消毒剂的需求增加

酒精类消毒剂因其能有效消除多种细菌而被用于临床设备。它易于使用且无毒，使其成为医疗应用的理想选择。消毒内视镜是临床器械的主要用途之一。内视镜通常使用酒精类消毒剂消毒和清洗。酒精消毒剂可有效杀死许多病菌，包括真菌、细菌和病毒。因此，医疗设备对酒精类消毒剂的需求不断增长可能会推动防腐剂和消毒剂市场的扩张。

预计北美将推动防腐剂和消毒剂市场

预计北美将成为防腐剂和消毒剂市场的股份持有人。随着北美医护人员和手术数量的增加，预计北美对消毒剂和防腐剂的需求将会增加。防腐剂和消毒剂对于外科手术和科学研究至关重要，因为它们可以最大限度地降低患者之间感染和污染的风险。此外，由于医院感染发生率增加以及医生处方感染疗法的调整，该地区正在经历成长。

主要企业专注于产品创新

防腐消毒剂製造商根据各种职业危害所需的防护等级，利用新颖、尖端的技术来生产和销售产品给不同的终端消费者，这对于扩大防腐消毒剂的市场占有率至关重要。例如，2021 年 1 月，加拿大卫生署在其有效对抗 SARS-CoV-2 的消毒剂清单中添加了五种庄臣家用清洗产品。这些消毒剂经庄臣批准可消灭 SARS-CoV-2，这种病毒在摩擦时会导致泡沫状的 COVID-19 症状。因此，由于许多公司之前和正在进行的开发，COVID-19 大流行产生了积极的商业性影响。

市场开拓的主要进展

2022 年 10 月，Deepak Fertilizers And Petrochemicals Corporation (DFPCL) 推出了 Cororid 消毒产品，以满足医院、诊所、实验室和其他医疗保健设施的独特需求。 2022年9月，利洁时及其品牌滴露将加入配送服务和本地旅游领域的领导者Deliveroo，透过可见消毒剂提高其服务的卫生标准，保障香港居民的日常需求。宣布与、顺丰速运、和优步。 2022 年 8 月，PDI 宣布推出独特且创新的消毒剂，以协助感染预防专业人员持续对抗 COVID-19 和日益增加的医疗相关感染疾病(HAI)。

介绍
北美洲
- 美国
- 加拿大
- 墨西哥
南美洲
- 巴西
- 阿根廷
- 其他的
欧洲
- 英国
- 德国
- 法国
- 西班牙
- 其他的
中东/非洲
- 沙乌地阿拉伯
- 阿拉伯聯合大公国
- 以色列
- 其他的
亚太地区
- 日本
- 中国
- 印度
- 韩国
- 印尼
- 泰国
- 其他的

第九章竞争环境及分析

主要企业及策略分析
新兴企业和市场盈利
合併、收购、协议和合作
供应商竞争力矩阵

第十章公司简介

PSK Pharma
ACTO GmbH
Dr. Schumacher GmbH
3M
Reckitt Benckiser
Steris Plc
Kimberly-Clark Corporation
Cardinal Health
BD

简介目录

Product Code: KSI061615753

The antiseptic and disinfectant market is estimated to grow at a CAGR of 12.38% during the forecast period.

Antiseptics are used in healthcare facilities for a wide range of topical and hard-surface applications. In contrast to antibiotics, the majority of these active compounds have broad-spectrum antimicrobial activity, although little is known about their method of action. Since antiseptics and disinfectants are used widely, there has been significant discussion over the emergence of microbial resistance, particularly about whether antimicrobial resistance is brought on by antiseptics or disinfectants.

Growth drivers fueling the antiseptic and disinfectant market

Rising instances of illness caused due to infections are a major growth driver for the antiseptic and disinfectant market. Precautions must be taken by people as the population around the world is prone to illness caused by infections. Extensive R&D programs are being carried out by industry leaders to manufacture new and improved products which is propelling the antiseptic and disinfectant market share. The growing investment by these manufacturers has also emerged as a crucial factor for the antiseptic and disinfectant market growth.

Rising incidence of HAIs

One of the main drivers of antiseptic and disinfectant market expansion is the rising prevalence of HAIs brought on by a lack of sanitation and safety measures. For instance, Healthcare-Associated Infections estimated that at least one HAI is required annually by approximately one in every twenty-five patients present in the hospital. Antiseptics and disinfectants play a significant role in overall contamination, prevention and lowering the frequency of HAIs. Antiseptic and disinfectant products protect the patient's body from any bacterial and microbial infections, which is further propelling the antiseptic and disinfectant market.

Multiple reimbursement policies are a major growth opportunity

Many attractive reimbursement plans are being offered by insurance firms to customers that would help them select cutting-edge technologies for treatment leading to antiseptic and disinfectant market growth. Reimbursement strategies are encouraged to make treatment options accessible for these people despite their low disposable income. As the number of people suffering from infectious illness increases the number of reimbursements that are being authorized also increases.

Surface disinfectants are showing growth potential

Chemical substances known as surface disinfectants are used to kill or render inactive bacteria on inert surfaces. These disinfectants function by rupturing microorganisms' cell walls or obstructing their metabolism. Infections that do not exist or are not incubating at the time a patient is admitted can be avoided by performing thorough surface cleaning. Surface disinfectants utilize several chemicals for various objectives. In non-healthcare contexts, sodium hypochlorite (bleach/chlorine) may be used at a recommended dosage of 0.1% or 1,000 ppm, according to World Health Organisation (WHO) data revised in March 2022. Also useful for surface sanitation is alcohol at 70-90% concentration.

Medical device disinfectants are anticipated to grow significantly

Surgical units and endoscopes are often reprocessed using medical equipment disinfectants. Phenol, hydrogen peroxide, peracetic acid, and glutaraldehyde are some of the disinfectants used for reprocessing or disinfecting medical devices. The risk of infection spreading from patient to patient due to skin contact is the reason why endoscopes and medical devices need to be disinfected. The rising number of surgical operations being performed globally is one of the primary factors propelling the antiseptic and disinfectant market growth.

Increasing demand for alcohol-based disinfectants

Alcohol-based disinfectants are utilized on clinical instruments due to their effectiveness in eliminating a wide variety of bacteria. They are ideal for medical applications because they are also simple to use and non-toxic. Disinfecting endoscopes is one of the main uses for clinical equipment. Endoscopes are often sterilized and cleaned using alcohol-based disinfectants. They efficiently eradicate many germs, including fungi, bacteria, and viruses. Thus, the growing need for alcohol-based disinfectants for medical equipment will probably promote antiseptic and disinfectant market expansion.

North America is anticipated to be the largest glaucoma market shareholder

North America is predicted to be the leading antiseptic and disinfectant market shareholder due to the increasing number of healthcare personnel working in North America and the growing number of operations, the demand for disinfectants and antiseptics in the region is anticipated to increase. Antiseptic and disinfection treatments are crucial for surgical procedures and scientific research because they minimize the danger of infection and contamination transferring from one patient to another. Furthermore, the region is experiencing growth due to a rise in the incidence of hospital-acquired infections and the adaption of doctor-prescribed infection therapies.

Key players focus on product innovation

Based on the level of protection necessary for various occupational hazards, antiseptics and disinfectant manufacturing businesses utilize novel and cutting-edge technologies to create, manufacture, and distribute goods to a variety of end consumers which is crucial in the expansion of antiseptic and disinfectant market share. For instance, Health Canada added five SC Johnson household cleaning products to its list of effective disinfectants for use against SARS-CoV-2 in January 2021. These disinfectants have been authorized by SC Johnson to destroy SARS-CoV-2, the virus that generates COVID-19 symptoms like bubbles when you scrub. The COVID-19 pandemic, therefore, had a favourable commercial impact as a result of previous and ongoing developments made by numerous firms.

Market Key Developments

In October 2022, Cororid disinfection products were introduced by Deepak Fertilisers And Petrochemicals Corporation (DFPCL) to meet the unique requirements of hospitals, clinics, labs, and other medical and healthcare setups.
In September 2022, Reckitt and its brand Dettol announced a partnership with delivery service and local travel leaders Deliveroo, SF Express, and Uber to safeguard the daily needs of Hong Kong residents by enhancing the hygiene standards of their services with visible disinfectants.
In August 2022, PDI announced the dual introduction of unique, innovative disinfectants to aid infection prevention experts in the ongoing fight against COVID-19 and the growing number of healthcare-associated infections (HAIs).

Segmentation:

By Type

Quaternary Ammonium Compounds
Chlorine Compounds
Alcohols & Aldehyde Products
Enzyme
Others

By Product

Enzymatic Cleaners
Medical Device Disinfectants
Surface Disinfectants

By End-Use

Hospitals
Clinics
Others

By Geography

North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
Japan
China
India
South Korea
Indonesia
Thailand
Others

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Data
2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Force Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. ANTISEPTIC AND DISINFECTANT MARKET, BY TYPE

5.1. Introduction
5.2. Quaternary Ammonium Compounds
5.3. Chlorine Compounds
5.4. Alcohols & Aldehyde Products
5.5. Enzyme
5.6. Others

6. ANTISEPTIC AND DISINFECTANT MARKET, BY PRODUCT

6.1. Introduction
6.2. Enzymatic Cleaners
6.3. Medical Device Disinfectants
6.4. Surface Disinfectants

7. ANTISEPTIC AND DISINFECTANT MARKET, BY END-USE

7.1. Introduction
7.2. Hospitals
7.3. Clinics
7.4. Others

8. ANTISEPTIC AND DISINFECTANT MARKET, BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. United States
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. United Kingdom
- 8.4.2. Germany
- 8.4.3. France
- 8.4.4. Spain
- 8.4.5. Others
8.5. The Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Israel
- 8.5.4. Others
8.6. Asia Pacific
- 8.6.1. Japan
- 8.6.2. China
- 8.6.3. India
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Others